{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:01:07Z","timestamp":1790870467651,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071961"],"award-info":[{"award-number":["82071961"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772893"],"award-info":[{"award-number":["81772893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Medical and Health Projects in Xiamen","award":["3502Z20191104"],"award-info":[{"award-number":["3502Z20191104"]}]},{"name":"National University of Singapore Start-up Grant","award":["NUHSRO\/2020\/133\/Startup\/08"],"award-info":[{"award-number":["NUHSRO\/2020\/133\/Startup\/08"]}]},{"name":"NUS School of Medicine Nanomedicine Translational Research Programme","award":["NUHSRO\/2021\/034\/TRP\/09\/Nanomedicine"],"award-info":[{"award-number":["NUHSRO\/2021\/034\/TRP\/09\/Nanomedicine"]}]},{"name":"NUS School of Medicine Kickstart Initiative","award":["NUHSRO\/2021\/044\/Kickstart\/09\/LOA"],"award-info":[{"award-number":["NUHSRO\/2021\/044\/Kickstart\/09\/LOA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00259-021-05587-7","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T08:30:41Z","timestamp":1634632241000},"page":"1360-1373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Somatostatin receptor imaging with [68Ga]Ga-DOTATATE positron emission tomography\/computed tomography (PET\/CT) in patients with nasopharyngeal carcinoma"],"prefix":"10.1007","volume":"49","author":[{"given":"Liang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhen","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-8884","authenticated-orcid":false,"given":"Haojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"issue":"10022","key":"5587_CR1","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","volume":"387","author":"MLK Chua","year":"2016","unstructured":"Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(15)00055-0.","journal-title":"Lancet"},{"issue":"10192","key":"5587_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)30956-0.","journal-title":"Lancet"},{"issue":"7","key":"5587_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41588-019-0436-5","volume":"51","author":"M Xu","year":"2019","unstructured":"Xu M, Yao Y, Chen H, Zhang S, Cao SM, Zhang Z, et al. Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma. Nat Genet. 2019;51(7):1131\u20136. https:\/\/doi.org\/10.1038\/s41588-019-0436-5.","journal-title":"Nat Genet"},{"issue":"1","key":"5587_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00259-008-0918-7","volume":"36","author":"SH Ng","year":"2009","unstructured":"Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Staging of untreated nasopharyngeal carcinoma with PET\/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging. 2009;36(1):12\u201322. https:\/\/doi.org\/10.1007\/s00259-008-0918-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"5587_CR5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s00259-005-1837-5","volume":"32","author":"RF Yen","year":"2005","unstructured":"Yen RF, Chen TH, Ting LL, Tzen KY, Pan MH, Hong RL. Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2005;32(10):1152\u20139. https:\/\/doi.org\/10.1007\/s00259-005-1837-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"5587_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5587_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1385\/ENDO:20:3:255","volume":"20","author":"P Barnett","year":"2003","unstructured":"Barnett P. Somatostatin and somatostatin receptor physiology. Endocrine. 2003;20(3):255\u201364. https:\/\/doi.org\/10.1385\/ENDO:20:3:255.","journal-title":"Endocrine"},{"issue":"3","key":"5587_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2967\/jnumed.112.111724","volume":"54","author":"D Wild","year":"2013","unstructured":"Wild D, Bomanji JB, Benkert P, Maecke H, Ell PJ, Reubi JC, et al. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET\/CT within patients with gastroenteropancreatic neuroendocrine tumors. J Nucl Med. 2013;54(3):364\u201372. https:\/\/doi.org\/10.2967\/jnumed.112.111724.","journal-title":"J Nucl Med"},{"issue":"5","key":"5587_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2967\/jnumed.116.185587","volume":"58","author":"M Barrio","year":"2017","unstructured":"Barrio M, Czernin J, Fanti S, Ambrosini V, Binse I, Du L, et al. The Impact of Somatostatin receptor-directed PET\/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis. J Nucl Med. 2017;58(5):756\u201361. https:\/\/doi.org\/10.2967\/jnumed.116.185587.","journal-title":"J Nucl Med"},{"issue":"1","key":"5587_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00259-008-0944-5","volume":"36","author":"M Miederer","year":"2009","unstructured":"Miederer M, Seidl S, Buck A, Scheidhauer K, Wester HJ, Schwaiger M, et al. Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET\/CT. Eur J Nucl Med Mol Imaging. 2009;36(1):48\u201352. https:\/\/doi.org\/10.1007\/s00259-008-0944-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"5587_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00428-020-02815-7","volume":"477","author":"L Tao","year":"2020","unstructured":"Tao L, Chen Y, Shi X, Yu G, Yin W, Huang Y. Expression of potential therapeutic target SSTR2a in primary and metastatic non-keratinizing nasopharyngeal carcinoma. Virchows Arch. 2020;477(4):573\u20139. https:\/\/doi.org\/10.1007\/s00428-020-02815-7.","journal-title":"Virchows Arch"},{"issue":"1","key":"5587_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00259-014-2905-5","volume":"42","author":"VH Schartinger","year":"2015","unstructured":"Schartinger VH, Dudas J, Url C, Reinold S, Virgolini IJ, Kroiss A, et al. (68)Ga-DOTA (0)-Tyr (3)-octreotide positron emission tomography in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2015;42(1):20\u20134. https:\/\/doi.org\/10.1007\/s00259-014-2905-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"5587_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41467-020-20308-8","volume":"12","author":"M Lechner","year":"2021","unstructured":"Lechner M, Schartinger VH, Steele CD, Nei WL, Ooft ML, Schreiber LM, et al. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy. Nat Commun. 2021;12(1):117. https:\/\/doi.org\/10.1038\/s41467-020-20308-8.","journal-title":"Nat Commun"},{"key":"5587_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04654-4","author":"L Zhao","year":"2020","unstructured":"Zhao L, Zhuang Y, Fu K, Chen P, Wang Y, Zhuo J, et al. Usefulness of [(18)F]fluorodeoxyglucose PET\/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2020. https:\/\/doi.org\/10.1007\/s00259-019-04654-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"5587_CR15","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47(8):1820\u201332. https:\/\/doi.org\/10.1007\/s00259-020-04769-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5587_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05336-w","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Zheng H, Han C, Gu J, Sun L, et al. Clinical utility of [(68)Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography\/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2021. https:\/\/doi.org\/10.1007\/s00259-021-05336-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"5587_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/PAS.0b013e31823d07f3","volume":"36","author":"M Korner","year":"2012","unstructured":"Korner M, Waser B, Schonbrunn A, Perren A, Reubi JC. Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting. Am J Surg Pathol. 2012;36(2):242\u201352. https:\/\/doi.org\/10.1097\/PAS.0b013e31823d07f3.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"5587_CR18","doi-asserted-by":"publisher","first-page":"E76","DOI":"10.1002\/hed.24164","volume":"38","author":"LK Khor","year":"2016","unstructured":"Khor LK, Loi HY, Sinha AK, Tong KT, Goh BC, Loh KS, et al. (68)Ga-DOTA-peptide: a novel molecular biomarker for nasopharyngeal carcinoma. Head Neck. 2016;38(4):E76-80. https:\/\/doi.org\/10.1002\/hed.24164.","journal-title":"Head Neck"},{"issue":"964","key":"5587_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1259\/bjr\/73751469","volume":"81","author":"AD King","year":"2008","unstructured":"King AD, Ma BB, Yau YY, Zee B, Leung SF, Wong JK, et al. The impact of 18F-FDG PET\/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol. 2008;81(964):291\u20138. https:\/\/doi.org\/10.1259\/bjr\/73751469.","journal-title":"Br J Radiol"},{"key":"5587_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109168","volume":"117","author":"WT Rahman","year":"2019","unstructured":"Rahman WT, Wale DJ, Viglianti BL, Townsend DM, Manganaro MS, Gross MD, et al. The impact of infection and inflammation in oncologic (18)F-FDG PET\/CT imaging. Biomed Pharmacother. 2019;117: 109168. https:\/\/doi.org\/10.1016\/j.biopha.2019.109168.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5587_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cpet.2019.11.001","volume":"15","author":"S Hess","year":"2020","unstructured":"Hess S, Scholtens AM, Gormsen LC. Patient preparation and patient-related challenges with FDG-PET\/CT in infectious and inflammatory disease. PET Clin. 2020;15(2):125\u201334. https:\/\/doi.org\/10.1016\/j.cpet.2019.11.001.","journal-title":"PET Clin"},{"issue":"23","key":"5587_CR22","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/jnci\/djr432","volume":"103","author":"QY Chen","year":"2011","unstructured":"Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, et al. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst. 2011;103(23):1761\u201370. https:\/\/doi.org\/10.1093\/jnci\/djr432.","journal-title":"J Natl Cancer Inst"},{"issue":"29","key":"5587_CR23","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","volume":"33","author":"AW Lee","year":"2015","unstructured":"Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015;33(29):3356\u201364. https:\/\/doi.org\/10.1200\/JCO.2015.60.9347.","journal-title":"J Clin Oncol"},{"key":"5587_CR24","doi-asserted-by":"publisher","unstructured":"Hennrich U, Kopka K. Lutathera((R)): The first FDA- and EMA-approved radiopharmaceutical for peptide receptor radionuclide therapy. Pharmaceuticals (Basel). 2019;12(3). doi:https:\/\/doi.org\/10.3390\/ph12030114.","DOI":"10.3390\/ph12030114"},{"issue":"12","key":"5587_CR25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/RLU.0000000000002788","volume":"44","author":"W Zhu","year":"2019","unstructured":"Zhu W, Zhang J, Singh A, Kulkarni HR, Baum RP. Metastatic nasopharyngeal carcinoma treated with intraarterial combined with intravenous peptide receptor radionuclide therapy. Clin Nucl Med. 2019;44(12):989\u201390. https:\/\/doi.org\/10.1097\/RLU.0000000000002788.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"5587_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00259-011-2003-x","volume":"39","author":"A Sainz-Esteban","year":"2012","unstructured":"Sainz-Esteban A, Prasad V, Schuchardt C, Zachert C, Carril JM, Baum RP. Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET\/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging. 2012;39(3):501\u201311. https:\/\/doi.org\/10.1007\/s00259-011-2003-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"5587_CR27","doi-asserted-by":"publisher","first-page":"101042831770551","DOI":"10.1177\/1010428317705519","volume":"39","author":"F Liu","year":"2017","unstructured":"Liu F, Zhu H, Yu J, Han X, Xie Q, Liu T, et al. (68)Ga\/(177)Lu-labeled DOTA-TATE shows similar imaging and biodistribution in neuroendocrine tumor model. Tumour Biol. 2017;39(6):1010428317705519. https:\/\/doi.org\/10.1177\/1010428317705519.","journal-title":"Tumour Biol"},{"issue":"7","key":"5587_CR28","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2967\/jnumed.110.085100","volume":"52","author":"JE Gains","year":"2011","unstructured":"Gains JE, Bomanji JB, Fersht NL, Sullivan T, D\u2019Souza D, Sullivan KP, et al. 177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma. J Nucl Med. 2011;52(7):1041\u20137. https:\/\/doi.org\/10.2967\/jnumed.110.085100.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05587-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05587-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05587-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T10:11:19Z","timestamp":1647252679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-021-05587-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5587"],"URL":"https:\/\/doi.org\/10.1007\/s00259-021-05587-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any experiments with animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}